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Purpose or Objective: An alternative approach for the 
improvement of radiotherapy consists in increasing 
differentially the radiation dose between tumors and healthy 
tissues using nanoparticles (NPs) that have been beforehand 
internalized into the tumor. These high-Z NPs can be photo-
activated by monochromatic synchrotron X-rays, leading to a 
local dose enhancement delivered to the neighboring tumor 
cells. This enhancement is due to secondary and Auger 
electrons expelled from the NPs by the radiations. In order to 
carry the NPs into the tumor center, macrophages are 
currently under study for their phagocytosis and diapedesis 
abilities. In this study we characterized J774A.1 
macrophages’ internalization kinetics and subcellular 
distribution of iron NPs and compared them to the 
internalization abilities of the F98 glioblastoma cell line. 
 
Material and Methods: Three aspects of internalization were 
examined: first, the location of internalized NPs in J774A.1 
macrophages and F98 glioblastoma cells following a 24h 
incubation with iron NPs (0.3 mg/mL in the cell culture 
medium) was determined by optical microscopy after cell 
slicing. Subsequently, the iron intake after a 24h incubation 
with NPs (0.3 mg/mL and 0.06 mg/mL in the cell culture 
medium) was characterized for the two types of cells using 
ICP-MS. Finally, the internalization dynamics were studied by 
live phase-contrast microscopy imagining for 11 hours and by 
absorbance measurements for 24 hours using a plate reader. 
 
Results: F98 tumor cells and J774A.1 macrophages are both 
able to endocytose NPs: we measured ~61±10 pg of 
internalized iron per macrophage compared with ~33±5 pg 
per F98 cell (initial iron concentration: 0.3 mg/mL in culture 
medium). F98 internalizing NPs for 10 hours showed stress 
signs during the first minutes after the NPs injection, but 
behaved like F98 control cells during the rest of the 
experiment. Finally, we determined that the internalization 
kinetics for J774A.1 had a typical saturation time of one 
hour. 
 
Conclusion: Macrophages seem to be promising vectors for 
NPs, being able to endocytose and retain in their cytoplasm 
larger quantities of NPs than tumor cells. Our following 
studies will attempt to shed light on their other potential 
abilities as “Trojan Horses”. 
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Purpose or Objective: Inhibitors of Wee1 are in clinical trials 
for cancer treatment in combination with radiation or 
chemo-therapy. The antitumor effects have largely been 
attributed to their role in G2 checkpoint abrogation. 
However, our previous work has shown that Wee1-inhibition 
also causes DNA damage in S phase. To understand 
mechanisms behind the S-phase damage and to identify 
promising combination treatments, we initiated a flow 
cytometry-based screen for compounds that increase S-phase 
damage when combined with the Wee1-inhibitor MK1775. 
 
Material and Methods: The screen was performed in 384-well 
plates by using a pipetting robot and a flow cytometer 
equipped with a plate loader. REH leukemia suspension cells 
were treated with the LOPAC 1280 and Selleck Cambridge 
cancer 384 compound libraries in the presence and absence 
of the Wee1 inhibitor MK1775 (4h, 400nM), stained with the 
DNA-stain Hoechst and the DNA damage marker yH2AX, and 
analyzed by flow cytometry using the FlowJo software. In 
addition to drugs present in the compound libraries, three 
additional Chk1-inhibitors (LY60638, MK8776 and UCN01) 
were included in subsequent validation experiments. 
 
Results: The Chk1 inhibitor AZD7762 was among the top hits 
of 1664 tested compounds, giving synergistically increased S-
phase damage when combined with MK1775. Similar effects 
were found with with three other Chk1-inhibitors. In 
addition, the screen identified several expected negative and 
positive regulators of the S phase damage, such as inhibitors 
of Cyclin-Dependent-Kinase (CDK) and Topoisomerase, and 
some unexpected hits such as Dasatinib. 
 
Conclusion: This study helps understanding how Wee1-
inhibition causes S-phase damage, and will likely identify 
combinations of MK1775 and drugs relevant for future clinical 
studies. These drug combinations may also be useful to apply 
together with radiation therapy to eliminate radioresistant S-
phase cells. 
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Purpose or Objective: Many experimental evidences proved 
the existence of radiation-induced abscopal effect (RIAE), a 
phenomenon of non-targeted radiobiological effect which is 
rarely, unintentionally induced in vivo, mostly with high 
doses per fraction. We explored different biological, 
biochemical and physical factors on which the type and 
intensity of RIAE could depend and whose manipulation could 
lead to induction of strong, clinically applicable RIAE. Also, 
the radio-sensitizing potential of abscopal signals (AS) and 
the status of RIAE in hypoxia (H) were examined. After 
observation of AS transmission by tumor cells exposed to H, 
which were able to affect proliferation of normoxic (N) and H 
cells, irradiated as well as unirradiated, we introduce a new 
scientific term:"Hypoxia-induced abscopal effect” (HIAE). 
 
Material and Methods: A549 and H460 lung cancer cells were 
incubated in H (Oxygen<2%) or N for 3 days and then 
irradiated (2 or 10Gy) or not. After 24h, unirradiated H (HCM) 
or N (NCM) conditioned media (CM) and irradiated H (HRCM) 
or N (NRCM) CM were collected. H-resistant (HR) clones 
A549/HR and H460/HR were generated by 3 weeks-exposure 
of cells to H. 2 identical sets of unirradiated N cells and HR 
clones were exposed to HCM, NCM, HRCM or NRCM and only 1 
set was irradiated (2Gy) to evaluate the radio-sensitizing 
potential of AS. Cell growth was monitored using real time 
cell electronic sensing system. Cell survival was assessed by 
colony forming assay. Levels of basic fibroblast growth factor 
(GF)(bFGF), placental GF (PlGF), Soluble fms-like tyrosine 
kinase (sFlt-1) and vascular endothelial GF (VEGF) were 
assessed in CM. 
